In vivo response to growth hormone-releasing peptide-6 in ACTH-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression (2007)
- Authors:
- Autor USP: GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM
- Unidade: FM
- Subjects: ADRENORECEPTORES; CARCINOMA; REAÇÃO EM CADEIA POR POLIMERASE; HORMÔNIO ADRENOCORTICOTRÓFICO; HORMÔNIO DO CRESCIMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Endocrinological Investigation
- ISSN: 0391-4097
- Volume/Número/Paginação/Ano: v. 30, n. 4, p. 334-340, 2007
-
ABNT
MACHADO, M. C. et al. In vivo response to growth hormone-releasing peptide-6 in ACTH-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. Journal of Endocrinological Investigation, v. 30, n. 4, p. 334-340, 2007Tradução . . Acesso em: 05 fev. 2026. -
APA
Machado, M. C., Sá, S. V., Goldbaum, T. S., Catania, M., Campos, V. C., Corrêa-Giannella, M. L. C., et al. (2007). In vivo response to growth hormone-releasing peptide-6 in ACTH-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. Journal of Endocrinological Investigation, 30( 4), 334-340. -
NLM
Machado MC, Sá SV, Goldbaum TS, Catania M, Campos VC, Corrêa-Giannella MLC, Giannella-Neto D, Salgado LR. In vivo response to growth hormone-releasing peptide-6 in ACTH-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. Journal of Endocrinological Investigation. 2007 ; 30( 4): 334-340.[citado 2026 fev. 05 ] -
Vancouver
Machado MC, Sá SV, Goldbaum TS, Catania M, Campos VC, Corrêa-Giannella MLC, Giannella-Neto D, Salgado LR. In vivo response to growth hormone-releasing peptide-6 in ACTH-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression. Journal of Endocrinological Investigation. 2007 ; 30( 4): 334-340.[citado 2026 fev. 05 ] - Expression analysis of proto-oncogene ret in patients with primary hyperparathyroidism: comparison between hyperplasia, adenoma and carcinoma
- Continuous glucose monitoring system: dawn period calibration does not change accuracy
- Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes
- Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]
- Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
- Association between tumor GHSR-IA mRNA expression and in vivo response to GHRP-6 in patients with ACTH-dependent Cushing`s syndrome
- Visceral adiposity syndrome
- Polymorphisms in the gene encoding glucose transporter Glut-1 (SLC2A1) and renal disease in type 1 diabetic patients
- 3111T/clock gene polymorphism is associated with metabolic changes in Brazilian obese children and adolescents
- Celiac crisis in an adult type 1 diabetes mellitus patient: a rare manifestation of celiac disease
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
